Two medicine lists and an unclear adverse event

A patient brings medicines from a recent hospital discharge together with an older list from the community pharmacy. Two brand names may represent the same ingredient, but the strengths and release forms have not been compared. The patient reports dizziness and has stopped one item without understanding whether it was intended to continue. Nonprescription products and supplements are not on either list. The pharmacist needs to clarify actual use, the therapeutic objectives and the event while considering whether prompt clinical review is needed. A list discrepancy and a new symptom can be connected without proving one cause, so the plan must preserve uncertainty and coordinate with the responsible care team.